Get started
RocketTickers

Lannett Receives FDA Approval For Aspirin And Extended-Release

Long
RocketTickers  
NYSE:LCI   None
Beyond Technical Analysis
1
0
beyondta
LCI: Lannett Company, Inc.
2019-03-27 06:52:00
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg - PR Newswire
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.